The consequences of long-term therapy with proton pump inhibitors

The consequences of long-term therapy with proton pump inhibitors

Introduction and purpose: Proton pump inhibitors (PPIs) were first developed in the late 1970s and introduced to the market in 1989. They are one of the most commonly prescribed medications worldwide. PPIs reduce gastric acid secretion in the stomach by inhibiting the hydrogen-potassium ATPas...

Full description

Bibliographic Details
Main Authors: Zuzanna Drygała, Julia Wyrwał, Martyna Krasuska, Karolina Nowak, Zuzanna Olejarz, Zuzanna Zielińska, Magdalena Słowik, Maria Nieć, Katarzyna Gierlach
Format: Article
Language:English
Published: Kazimierz Wielki University 2024-01-01
Series:Journal of Education, Health and Sport
Subjects:
proton pump inhibitors
gastric acid
omeprazole
lansoprazole
cardiovascular system
micronutrients
Online Access:https://apcz.umk.pl/JEHS/article/view/47928

Internet

https://apcz.umk.pl/JEHS/article/view/47928

Similar Items